Novel compounds

The present invention relates to 4-(1-hydroxy-3, 4-dihydro-1H-benzo [c] [1, 2] oxaborin-3-yl) benzamidine derivatives and their use in the treatment of skin diseases and conditions (e.g., Neethton Syndrome, rosacea, atopic dermatitis, psoriasis and pruritus) caused by very high levels of protease ac...

Full description

Saved in:
Bibliographic Details
Main Authors BOUILLOT AURELIEN, FORCHE MARC-HENRI, DODIC NIKOLA, WHITE GORDON V, LIDDLE JOHN, DENIS ARNAUD, WALKER ANN LOUISE
Format Patent
LanguageChinese
English
Published 06.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to 4-(1-hydroxy-3, 4-dihydro-1H-benzo [c] [1, 2] oxaborin-3-yl) benzamidine derivatives and their use in the treatment of skin diseases and conditions (e.g., Neethton Syndrome, rosacea, atopic dermatitis, psoriasis and pruritus) caused by very high levels of protease activity, in particular serine proteases such as kallikrein. Furthermore, the invention relates to a composition containing the derivative and a method for preparing the same. 本发明涉及4-(1-羟基-3,4-二氢-1H-苯并[c][1,2]氧杂硼杂环已-3-基)苄脒衍生物及其在治疗由异常高水平的蛋白酶活性(特别是丝氨酸蛋白酶,如激肽释放酶)引起的皮肤疾病和病症中的用途(例如Netherton综合征、酒渣鼻、特应性皮炎、银屑病和瘙痒)。此外,本发明涉及含有该衍生物的组合物及其制备方法。
Bibliography:Application Number: CN202310268678